Skip to main content

Natixis

SEC CIK
0001274981
Latest filing
Aug 13, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of ELV by Natixis, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−119,350−100.0%Sold outHolders
Q1 2026119,350$34.9M0.1%+109,484+1,109.7%AddedHolders
Q4 20259,866$3.46M<0.1%−291,570−96.7%ReducedHolders
Q3 2025301,436$97.4M0.5%+260,329+633.3%AddedHolders
Q2 202541,107$16.0M0.1%−55,088−57.3%ReducedHolders
Q1 202596,195$41.8M0.2%−37,510−28.1%ReducedHolders
Q4 2024133,705$49.3M0.3%+54,931+69.7%AddedHolders
Q3 202478,774$41.0M0.2%−15,271−16.2%ReducedHolders
Q2 202494,045$51.0M0.3%+3,651+4.0%AddedHolders
Q1 202490,394$46.9M0.3%−26,252−22.5%ReducedHolders
Q4 2023116,646$55.0M0.4%+31,882+37.6%AddedHolders
Q3 202384,764$36.9M0.3%+18,142+27.2%AddedHolders
Q2 202366,622$29.6M0.3%+61,562+1,216.6%AddedHolders
Q1 20235,060$2.33M<0.1%−71,982−93.4%ReducedHolders
Q4 202277,042$39.5M0.2%+19,347+33.5%AddedHolders
Q3 202257,695$26.2M0.1%+31,796+122.8%AddedHolders
Q2 202225,899$12.5M<0.1%−75,080−74.4%ReducedHolders
Q1 2022100,979$49.6M0.2%+22,310+28.4%AddedHolders
Q4 202178,669$36.5M0.1%+30,667+63.9%AddedHolders
Q3 202148,002$17.9M0.1%−51,854−51.9%ReducedHolders
Q2 202199,856$38.1M0.2%+24,739+32.9%AddedHolders
Q1 202175,117$27.0M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.